Letters, Testimony & Comments
Dear Majority Leader Reid and Minority Leader McConnell:
On behalf of the Biotechnology Industry Organization (BIO) and its more than 1...
March 16 2012
William D. Waddill, Senior Vice President and Chief Financial Officer OncoMed Pharmaceuticals highlights the importance of capital...
March 6 2012
December 1, 2011
On December 1, BIO submitted written testimony to the Senate Committee on Banking, Housing, and Urban Affairs on the importance of...
December 1 2011
May 17, 2011
Dear Chairman Frelinghuysen and Ranking Member Visclosky:
On behalf of the Biotechnology Industry Organization (BIO), I am writing to...
May 17 2011
BIO Requests for FY 2012 Agriculture, Rural Development, FDA and Related Agencies Appropriations Act
May 12, 2011
Dear Chairman Kingston and Ranking Member Farr:
On behalf of the Biotechnology Industry Organization (BIO), I am writing to encourage...
May 12 2011
April 7, 2011
Hearing Testimony
Scott Koenig, M.D., PH.D.
Before the House of Representatives Committee on Small Business
Good morning Chairman...
April 7 2011
April 1, 2011
Re: Request for Comments on the Strategy for American Innovation
Subject: Innovation Strategy RFI
Email: competitiveness@doc.gov
Dear...
April 1 2011
March 24, 2011
On behalf of the Biotechnology Industry Organization (BIO) and its more than 1,100 member companies, academic institutions, state...
March 24 2011
February 25, 2011
Dear Majority Leader Reid and Minority Leader McConnell:
On behalf of the Biotechnology Industry Organization (BIO), Advanced Biofuels...
February 25 2011
January 11, 2011
Dear President Obama:
The organizations below urge your Administration to maintain robust funding levels for the Department of...
January 11 2011
January 11, 2011
January 7, 2011
President's Council of Advisors on Science and Technology (PCAST)
Public Oral Comments
Ladies and Gentlemen:...
January 11 2011
September 20, 2010
Dear President Obama:
We are writing to ask for your support to provide additional guidance to the Department of Energy’s (DOE)...
September 20 2010
August 3, 2010
BIO advocated for the recently enacted new Therapeutic Discovery Project Credit program, which was created as a unique opportunity for...
August 3 2010
July 20, 2010
BIO long has argued that actual and potential conflicts of interest in research should be identified, disclosed, and appropriately...
July 20 2010
June 23, 2010
A letter to the House Ways & Means Committee by 54 trade organizations and companies supporting the extension of cellulosic biofuel...
June 23 2010
June 1, 2010
Dear Chairman Inouye and Ranking Member Cochran:
As the Senate debates fiscal year 2011 federal funding, the undersigned organizations...
June 1 2010
May 27, 2010
Access to Early Capital
In the United States and globally, commercial development of biotechnology relies on the continuing...
May 27 2010
May 17, 2010
BIO and 34 companies and trade organizations sent a letter to Chairman Levin and Ranking Member Camp, of the House Ways and Means...
May 17 2010
October 14, 2009
Good morning Chairwoman Velázquez, Ranking Member Graves, Members of the Committee, the Staff of the Committee, ladies and...
October 14 2009
April 23, 2009
Good morning Chairman Wu, Ranking Member Smith, Members of the Committee, ladies and gentleman. I am Jim Greenwood, President and CEO of...
April 23 2009
November 15, 2008
BIO urges that changes to FIN46(R) accurately reflect the underlying economics of collaborations.
November 15 2008
September 18, 2008
The letter, signed by approximately 60 patient groups, emphasizes support for restoring eligibility in the SBIR program to venture-backed...
September 18 2008
October 27, 2007
BIO addresses concerns to FASB’s Staff Position on accounting for instrument C and conventional convertible debt.
October 27 2007
July 26, 2005
The letter, signed by over 280 biotech executives, emphasizes support for restoring eligibility in the SBIR program to venture-backed...
July 26 2005
March 25, 2004
March 25 2004
December 10, 2003
December 10 2003
November 4, 2003
To Hector Barreto, Administrator, U.S. Small Business Administration
November 4 2003
October 21, 2003
To Hector Barreto, Administrator, U.S. Small Business Administration
October 21 2003
July 7, 2003
July 7 2003
We respectfully request that the Senate Appropriations Subcommittee of Labor, Health and Human Services, Education and Related Agencies...
On behalf of its members, the Biotechnology Industry Organization (BIO) is pleased to provide comments on the proposed rulemaking by the...
DEPARTMENT OF COMMERCE
National Institute of Standards and Technology
Docket Number: [100407180-0225-02]
Technology...
The Cures Acceleration Network, passed in the recently enacted healthcare reform bill, will provide funding to public and private...
Letters, Testimony & Comments
March 16 2012
Dear Majority Leader Reid and Minority Leader McConnell:
On behalf of the Biotechnology Industry Organization (BIO) and its more than 1...
March 6 2012
William D. Waddill, Senior Vice President and Chief Financial Officer OncoMed Pharmaceuticals highlights the importance of capital...
December 1 2011
On December 1, BIO submitted written testimony to the Senate Committee on Banking, Housing, and Urban Affairs on the importance of...
May 17 2011
Dear Chairman Frelinghuysen and Ranking Member Visclosky:
On behalf of the Biotechnology Industry Organization (BIO), I am writing to...
BIO Requests for FY 2012 Agriculture, Rural Development, FDA and Related Agencies Appropriations Act
May 12 2011
Dear Chairman Kingston and Ranking Member Farr:
On behalf of the Biotechnology Industry Organization (BIO), I am writing to encourage...
Press Releases
June 14 2012
WASHINGTON, DC (June 12, 2012) – The Biotechnology Industry Organization (BIO) announced today that New Jersey...
June 6 2012
Washington, DC and New York, NY, Wednesday, June 6, 2012 -The 4th Annual Scientific American Worldview Report and...
December 6 2011
Washington, DC (December 6, 2011) – The Biotechnology Industry Organization (BIO) announces program topics...
November 16 2011
Self-Funding Program Supported by Leading Biotech Trade Associations
WASHINGTON, D.C. (November 16, 2011)...
November 2 2011
Washington, DC (November 2, 2011) – The Biotechnology Industry Organization (BIO) strongly supports the Small...
Receive our newsletter from BIOtechNOW
Business Solutions Sponsor
